WEBINAR

The Automation Conversation: What Pharma and Flow Cores Can Learn from Each Other

Experts from AbbVie and GLIIFCA on modernizing flow cytometry workflows with automation

“We had a bunch of disparate instruments and I had to carry plates from one instrument to another…The missing link was washing.”

-Ryan Duggan

AbbVie

Get the Recording

60 minutes • Immediate access

Overview

Automation in flow cytometry is no longer a future aspiration—it’s quickly becoming essential as panel complexity, sample volume, and reproducibility demands increase. In this recorded webinar, Ryan Duggan (Principal Research Scientist, AbbVie) and David Leclerc (Technical Director, University of Chicago and President, GLIIFCA) discuss practical approaches for adopting automation in research and core environments.

What You'll Learn

Why Flow Cytometry Faces an Automation Gap

The speakers outline common constraints preventing adoption—rigidity concerns, staffing fears, fragmented workflows—and explain why complexity growth (e.g., high-parameter panels, spectral systems) is outpacing manual techniques.

Where Manual Workflows Fail

Staff are tied up with 200+ pipetting actions per plate
Centrifugation and flick-washing create variability and biohazard exposure
Reproducibility challenges in preclinical research translate into real financial impact

Practical Considerations for Cores and Pharma Teams

The discussion covers throughput expectations, panel design implications, SOP logic, and what builds (or erodes) user confidence during onboarding.

Who Should Watch

This webinar is designed for:

Automation and operations leaders in biotech and pharma
Flow cytometry core directors and managers
Researchers running high-throughput or high-parameter assays
Labs struggling with reproducibility, sample loss, or manual workflow limitations
Teams evaluating Curiox’s centrifuge-free automation technology